Notably, PSMC6 was expressed higher in LUAD with residual tumor than those without (Figure 2(a), p value < 0.01), suggesting that PSMC6 was associated with residual tumor, which was considered a risk factor of tumor recurrence [28, 29]. Here, PSMC6 is linked to neoplasm.